Advertisement
Lipella Pharma Soars 48% After FDA Oks IND For LP-310 For Oral Lichen Planus
(RTTNews) - Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced Friday that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for a multi-center, phase-2a, dose-escalation clinical trial.
The trial will assess the safety and efficacy of LP-310 in patients with symptomatic oral lichen planus (OLP), a highly morbid condition with no effective treatment.
In March 2023, Lipella created a five-member Scientific Advisory Board in Oral Health, made up of a group of highly regarded experts in oral medicine, to focus on the development of LP-310.
read more
Lipella Pharma Announces Top Line Results In Phase 2A Trial Of LP-10 For Hemorrhagic Cystitis
Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced top line results for its recently completed Phase 2a clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for Hemorrhagic Cystitis, a rare but highly morbid disease for which there are currently no FDA approved treatments.
RTTNews
|
il y a 986
Bay Street Likely To Post New Highs
Canadian shares are likely to open on a firm note Tuesday morning with higher oil and bullion prices set to trigger buying in energy and materials sectors.
RTTNews
|
il y a 3h 15min
Wall Street Likely To Open Flat
Futures point to a somewhat flat start on Wall Street Tuesday morning. Data on manufacturing and services sector activity in the U.S. in the month of August, due after the opening bell, is likely to provide some direction to the market.
RTTNews
|
il y a 3h 55min
Sweden Cuts Policy Rate By 25 Bps
Sweden's central bank cut its benchmark interest rate by 25 basis points in order to support economic recovery and signalled an end to the easing cycle. The executive board of the Riksbank decided to lower the policy rate by 25 basis points to 1.75 percent. The bank has reduced the rate by 200 basis points since it started policy easing in May 2024.
RTTNews
|
il y a 4h 1min
FTSE 100 Flat; Kingfisher Soars On Higher Guidance
U.K. stocks are turning in a mixed performance on Tuesday with investors digesting the flash data showing weak manufacturing and services sector activity in the month of September.
RTTNews
|
il y a 4h 54min
Eurozone Private Sector Logs Strongest Growth In 16 Months
The euro area private sector expanded the most in 16 months in September driven by the acceleration in services activity growth, flash survey results published by S&P Global revealed on Tuesday. At 51.2, the HCOB composite output index climbed slightly from August's 51.0 and was above forecast of 51.1. The index posted above the 50.0 no-change mark for the ninth straight month in September.
RTTNews
|
il y a 5h 4min
CAC 40 Up 0.6%; STMicroElectronics Rises Sharply
Despite data showing a contraction in France's private sector activity in the month of September, French stocks are up firmly in positive territory Tuesday afternoon with data showing an acceleration in Eurozone private sector growth, and NVIDIA's plans to invest $100 billion in OpenAI aiding sentiment.
RTTNews
|
il y a 5h 21min
Sensex, Nifty Recover From Early Lows
Indian shares cut early losses to end on a flat note on Tuesday. While a weakening rupee, tariff worries and concerns regarding the latest H1-B visa fee change weighed on markets, Fed rate cut hopes, falling oil prices and reports of strong festive-season demand for automobiles helped limit overall losses in the broader market.
RTTNews
|
il y a 5h 39min
